Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO

Open Access

14 August 2007

journal article
research article
Published by Oxford University Press (OUP) in Journal of Leukocyte Biology

Vol. 82 (5) , 1106-1114
https://doi.org/10.1189/jlb.0905519

Abstract

Journal of Leukocyte Biology considers manuscripts of original investigations focusing on the origins, developmental biology, biochemistry and functions of granulocytes, lymphocytes, mononuclear phagocytes, and other cells involved in host defense. These include full-length papers on original research, rapid communications of new discoveries, letters, commentaries, and invited reviews.

Keywords

Funding Information

Thurgauische Stiftung für Wissenschaft und Forschung
Swiss State Secretariat for Education and Research
Vontobel Stiftung
German Research Foundation (DFG, TR-SFB 11)
Thurgauische Krebsliga

This publication has 42 references indexed in Scilit:

Dendritic Cell-Based Tumor Vaccines and Antigen Presentation Attenuators
Molecular Therapy, 2006
Dendritic cells as therapeutic vaccines against cancer
Nature Reviews Immunology, 2005
CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2
Blood, 2004
Tolerance, DCs and tryptophan: much ado about IDO
Trends in Immunology, 2003
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Science, 2002
Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets
Blood, 2002
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells
Blood, 2002
Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase
The Journal of Experimental Medicine, 2002
Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells
The Journal of Experimental Medicine, 2002
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
The Journal of Experimental Medicine, 1994